Login / Signup

Risk assessment according to IPSS-M is superior to AML ELN risk classification in MDS/AML overlap patients defined by ICC.

Sandra HuberConstance BaerStephan HutterFrank DickerIrene FuhrmannManja MeggendorferChristian PohlkampWolfgang KernTorsten HaferlachClaudia HaferlachGregor Hoermann
Published in: Leukemia (2023)
Keyphrases